The role of nitric oxide in articular cartilage breakdown in osteoarthritis

Current Opinion in Rheumatology

Volumn 10, Issue 3, 1998, Pages 263-268

  Amin, Ashok R ^a   Abramson, Steven B ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; INTEGRIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEOGLYCAN;

APOPTOSIS; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REVIEW; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; DINOPROSTONE; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-17; INTERLEUKINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS;

EID: 0031833414     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199805000-00018     Document Type: Review

References (44)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
2. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
4. Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, Stuchin SA, Abramson SB: The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995, 182:2097-2102.
5. St.Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DL, Weinberg JB: Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996, 184:1173-1178. Interesting paper that demonstrates increased iNOS expression in the circulating mononuclear cells in patients with rheumatoid arthritis.
6. Christopherson KS, Bredt DS: Perspectives series: nitric oxide and nitric oxide syntheses. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 1997, 100:2424-2429.
7. Nathan C: Perspectives series: nitric oxide and nitric oxide syntheses. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997, 100:2417-2423. Excellent review with thoughtful speculations.
8. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718.
9. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
10. Lamas S, Mardsden PA, Li GK, Tempst P, Michel T: Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 1992, 89:6348-6352.
11. Crane BR, Arvai AS, Gachhui R, Wu C, Ghosh DK, Getzoff ED, Stuehr DJ, Tainer JA: The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997, 278:425-431. Crystal structure with identification of heme and arginine binding sites.
12. Michel T, Feron O: Nitric oxide syntheses: which, where, how and why? J Clin Invest 1997, 100:2146-2152.
13. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 1992, 258:1898-1902.
14. Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, Cook J, Pacelli R, Liebmann J, Krishna M, et al.: Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul 1996, 34:159-187.
15. Stefanovic-Racic M, Stadler J, Evans CH: Nitric oxide and arthritis. Arthritis Rheum 1993, 36:1036-1044.
16. Pelletier J-P, Jovanovic D, Fernandez JC, Geng C, Manning P, Connor JR, Dibattista J, Martel-Pelletier J: Selective inhibition of nitric oxide synthase reduces in vivo the progression of experimental osteoarthritic lesions and production of metalloproteases and interleukin-1 [abstract]. Arthritis Rheum 1997, 40(suppl):S173.
17. Farrell AJ, Blake D, Palmer RMJ, Moncada S: Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992, 51:1219-1222.
18. Renoux M, Hilliquin P, Galoppin L, Florentin I, Menkes CJ: Release of mast cell mediators and nitrites into knee Joint fluid in osteoarthritis: comparison with articular chondrocalcinosis and rheumatoid arthritis. Osteoarthritis Cartilage 1996, 4:175-179.
19. Takahashi T, Kondoh T, Kamei K, Seki H, Fukuda M, Nagai H, Takano H, Yamazaki Y: Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 1996, 82:505-509.
20. Hilliquin P, Borderie D, Hernvann A, Menkes CJ, Elkindjian OG: Nitric oxide as s-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 1997, 40:1512-1517.
21. Sakurai H, Kohsaka H, Liu M-F, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasala N: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1996, 96:2357-2363. First demonstration of iNOS in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis.
22. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE: Nitric oxide production by superficial and deep articular chondrocyte. Arthritis Rheum 1997, 40:261-269. Important observation that demonstrates that the predominant site of iNOS production in cartilage is superficial zone chondrocytes, consistent with prior reports that these are also cells producing interleukin-1β.
23. Grabowski PS, Wright PK, Van't Hof RJ, Helfrich MH, Ohshima J, Ralston SH: Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1997, 36:651-655.
24. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY: Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996, 184:1519-1524. Interesting observation using double-stain immunocytochemistry of synovial tissue to localize cellular site of iNOS upregulation.
25. Hukkanen M, Corbett SA, Batten J, Kont Tinen YT, McCarthy ID, Maclouf J, Satavirta S, Hughes SP, Polak JM: Aseptic loosening of total hip replacement: macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg Br 1997, 79:467-474.
26. Mayhan WG: Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5́-diphosphate and bradykinin. Inflammation 1996, 16:295-305.
27. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an x-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A 1994, 91:4190-4194.
28. Clancy R, Abramson SB, Kohne C, Rediske J: Nitric oxide attenuates cellular hexose monophosphate shunt response to oxidants in articular chondrocytes and acts to promote oxidant injury. J Cell Physiol 1997, 172:183-191.
29. Clancy R, Rediske J, Tang X, Nijher N, Frenkel S, Philips M, Abramson SB: Outside-in signaling in the chondrocyte: nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/Rho A/focal adhesion kinase signaling complex. J Clin Invest 1997, 100:1789-1796. Demonstrates cytoskeletal protein complex formation induced by fibronectin ligation of β1 intergrins in chondrocytes. NO and interleukin-1 (via NO mechanisms) disrupt formation of this intracellular signaling complex.
30. Blanco FJ, Lotz M: UK-1 induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 1995, 218:319-325.
31. Turpaev KT, Amchenkova AM, Narovlyansky AN: Two pathways of the nitric oxide-induced cytotoxycal action. Biochem Mol Biol Int 1997, 41:1025-1033.
32. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, Hebda PA, Stefanovic-Racic M, Evans CH: Nitric oxide inhibits the synthesis of type-II collagen without altering Co12A1 mRNA abundance: prolyl hydroxylase as a possible target Biochem J 1997, 324:305-310. Interleukin-1 inhibits type-ll collagen synthesis via NO dependent and independent mechanisms. NO mechanism appears to be caused by inhibition of prolyl hydroxylase, an important enzyme in the posttranslocational processing of collagen.
33. Pelletier J-P, Mineau F, Ranger P, Tardiff G, Martel-Pelletier J: The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation [abstract]. Arthritis Rheum 1996, 38(suppl):S313-S313.
34. Das P, Schurman DJ, Smith RL: Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear. J Orthop Res 1997, 15:87-93.
35. Maier R, Bilbe G, Rediske J, Lotz M: Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochem Biophys Acta 1994, 1208:145-150.
36. Geng Y, Blanco F, Cornelison M, Lotz M: Regulation of inducible cyclooxygenase in human articular chondrocytes. J Immunol 1995, 155:796-801.
37. Evans C, Watkins SC: Nitric oxide and cartilage metabolism. Methods Enzymol 1996, 269:75-88.
38. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, Dawson VL: Neuronal (type 1) nitric oxide synthase regulates nuclear factor kB activity and immunologie (type II) nitric oxide synthase expression. Proc Natl Acad Sci U S A 1997, 94:2676-2680.
39. 2 production.
40. 2, and IL-8. Proc Assoc Am Physicians 1998, 110:1-8.
41. Broxmeyer HE: Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? J Exp Med 1997, 183:2411-2415.
42. Attur MG, Patel RN, Abramson SB, Amin AR: Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 1997, 40:1050-1053.
43. Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissmann G, Abramson SB: The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci U S A 1995, 92:7926-7930.
44. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB: A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 1996, 93:14014-14019.